Ezrin immunoreactivity reveals specific astrocyte activation in cerebral HIV.
The actin-binding protein ezrin is associated with cellular shape changes, motility, tumor invasion, and lymphocyte activation. We have earlier shown that ezrin immunoreactivity (IR) is faintly present in normal astrocytes but increased in malignant human astrogliomas. We studied the role of ezrin in astrocyte activation, applying immunostaining on serial paraffin sections from human autopsied brain tissues (51 cases). Cerebral HIV infection was chosen as a model displaying consistent exemplary astrocyte activation. Semiquantitative ezrin-IR was compared with the common glial markers GFAP, ferritin, and HLA-DR in relation to clinical and morphologic criteria of HIV encephalopathy. In all cases with HIV infection, GFAP-, HLA-DR-, and ferritin-IR were elevated in comparison to normal brain tissues. In contrast, high ezrin-IR in HIV infection strictly correlated with additional HIV encephalopathy. HIV encephalopathy with particularly high ezrin-IR was correlated with neuronal apoptosis (TUNEL). Combined ezrin-IR and GFAP-IR thus reveals 2 distinct states of astrocytic activation. Normal ezrin-IR, when paralleled by upregulated GFAP, reflects astroglial activation not associated with neuronal apoptosis. High ezrin-IR indicates specific astrocyte stressors related to cellular damage within the central nervous system. Ezrin-IR might also provide a diagnostic tool for the classification of HIV encephalopathy.
Geiger
Kathrin D
KD
Edinger-Institute, JWG-University, Frankfurt/Main, Germany. geiger@pathologie.med.tu-dresden.de
Stoldt
Peter
P
Schlote
Wolfgang
W
Derouiche
Amin
A
D015526:AIDS Dementia Complex / Q000145:classification / Q000378:metabolism* / Q000473:pathology*; D017209:Apoptosis / Q000502:physiology; D001253:Astrocytes / Q000378:metabolism* / Q000473:pathology; D002452:Cell Count / Q000379:methods; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D005260:Female; D005293:Ferritins / Q000378:metabolism; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D015658:HIV Infections / Q000378:metabolism / Q000473:pathology; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D020287:In Situ Nick-End Labeling / Q000379:methods; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D011180:Postmortem Changes; D013997:Time Factors; D000099149:Ezrin
D003598:Cytoskeletal Proteins; D005293:Ferritins; D005904:Glial Fibrillary Acidic Protein; D006684:HLA-DR Antigens; D000099149:Ezrin